Michael Luo CFA
Stock Analyst at CLSA
(3.62)
# 2,076
Out of 4,442 analysts
75
Total ratings
48.6%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Michael Luo CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Upgraded: Buy | $164 → $219 | $186.60 | +17.36% | 4 | May 29, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $58.90 → $52.10 | $32.70 | +59.33% | 8 | Oct 30, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $137.10 → $138.60 | $141.60 | -2.12% | 13 | Oct 27, 2025 | |
| HKG: 6078 Hygeia Healthcare Holdings Co., Limited | Maintained: Buy | $17.30 → $17.00 | $8.95 | +89.94% | 6 | Aug 29, 2025 | |
| HKG: 1951 Jinxin Fertility Group Limited | Maintained: Buy | $3.80 → $3.50 | $2.05 | +70.73% | 3 | Aug 28, 2025 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Buy | $74.30 → $110.20 | $107.10 | +2.89% | 7 | Aug 27, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $34.80 → $42.60 | $32.92 | +29.40% | 9 | Aug 25, 2025 | |
| HKG: 0867 China Medical System Holdings Limited | Maintained: Buy | $10.00 → $15.60 | $10.01 | +55.84% | 4 | Aug 20, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Maintained: Buy | $27.80 → $43.10 | $30.26 | +42.43% | 2 | Aug 20, 2025 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Maintained: Buy | $7.00 → $9.20 | $4.44 | +107.21% | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,230 | $2,177.00 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,490 | $3,569.00 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63.00 → $42.00 | $26.28 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 702.00 → CHF 723.00 | $515.20 | n/a | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,850 | $1,639.50 | n/a | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9.80 → $11.00 | $17.31 | n/a | 3 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.50 | $0.98 | n/a | 1 | Apr 4, 2024 |
Charles River Laboratories International
May 29, 2026
Upgraded: Buy
Price Target: $164 → $219
Current: $186.60
Upside: +17.36%
Hangzhou Tigermed Consulting Co., Ltd
Oct 30, 2025
Maintained: Buy
Price Target: $58.90 → $52.10
Current: $32.70
Upside: +59.33%
WuXi AppTec Co., Ltd.
Oct 27, 2025
Maintained: Buy
Price Target: $137.10 → $138.60
Current: $141.60
Upside: -2.12%
Hygeia Healthcare Holdings Co., Limited
Aug 29, 2025
Maintained: Buy
Price Target: $17.30 → $17.00
Current: $8.95
Upside: +89.94%
Jinxin Fertility Group Limited
Aug 28, 2025
Maintained: Buy
Price Target: $3.80 → $3.50
Current: $2.05
Upside: +70.73%
Asymchem Laboratories (Tianjin) Co., Ltd.
Aug 27, 2025
Maintained: Buy
Price Target: $74.30 → $110.20
Current: $107.10
Upside: +2.89%
WuXi Biologics (Cayman) Inc.
Aug 25, 2025
Maintained: Buy
Price Target: $34.80 → $42.60
Current: $32.92
Upside: +29.40%
China Medical System Holdings Limited
Aug 20, 2025
Maintained: Buy
Price Target: $10.00 → $15.60
Current: $10.01
Upside: +55.84%
Hansoh Pharmaceutical Group Company Limited
Aug 20, 2025
Maintained: Buy
Price Target: $27.80 → $43.10
Current: $30.26
Upside: +42.43%
Sino Biopharmaceutical Limited
Jul 21, 2025
Maintained: Buy
Price Target: $7.00 → $9.20
Current: $4.44
Upside: +107.21%
May 20, 2025
Maintained: Buy
Price Target: ¥3,230
Current: $2,177.00
Upside: n/a
May 20, 2025
Maintained: Buy
Price Target: ¥2,490
Current: $3,569.00
Upside: n/a
Apr 8, 2025
Maintained: Buy
Price Target: $63.00 → $42.00
Current: $26.28
Upside: n/a
Dec 12, 2024
Maintained: Buy
Price Target: CHF 702.00 → CHF 723.00
Current: $515.20
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: ¥2,850
Current: $1,639.50
Upside: n/a
Apr 10, 2024
Upgraded: Buy
Price Target: $9.80 → $11.00
Current: $17.31
Upside: n/a
Apr 4, 2024
Maintained: Sell
Price Target: $1.50
Current: $0.98
Upside: n/a